Home
Betta Pharmaceuticals

Betta Pharmaceuticals Market Share Analysis for August 2026

贝达药业股份有限公司成立于2003年，总部位于浙江杭州，是一家由海归高层次人才团队创办的、以自主知识产权创新药物研究和开发为核心，集研发、生产、营销于一体的国家级高新技术企业。电话：0571-86130357

Health > Biotechnology and Pharmaceuticals

Domainbettapharma.com

Year Founded--

Employees51 - 200

Annual Revenue$200M - $500M

Betta Pharmaceuticals

Betta Pharmaceuticals (including company regionals)

bettapharma.com

See more website traffic and engagement information

Betta Pharmaceuticals Revenue up to August 2026 is 200M - 500M

revenue generated by Betta Pharmaceuticals top domains

Betta Pharmaceuticals top domains revenue over 3 years

Revenue for Betta Pharmaceuticals top domains

bettapharma.com200M - 500M

See more with Sales Intelligence

Total visits to Betta Pharmaceuticals's top domains

Understand Betta Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

bettapharma.com13.8K

See more with Sales Intelligence

Avg. visit duration in Betta Pharmaceuticals's top domains

Analyze Betta Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

bettapharma.com00:08:02

See more with Sales Intelligence

Avg. pageviews on Betta Pharmaceuticals's top domains

See how Betta Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

bettapharma.com7.62

See more with Sales Intelligence

Betta Pharmaceuticals top competitors by domain

Top similar sites in August 2026, ranked by their affinity

serb.comCompany NameSERB PharmaceuticalsEmployees501 - 1000HQLuxembourg, LuxembourgAnnual revenue$10M - $15MTotal visits18.5KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Betta Pharmaceuticals

These are the website technologies, by industry, used by Betta Pharmaceuticals top domains

Advertising (4)

PubMatic

Mobile (2)

Meta Viewport

Widget (2)

FancyBox

Conversion & Analytics (1)

Baidu Analytics

More Technologies

2

See all

News & Signals from Betta Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBettapharma is developing X-396 on Jan 1st '26.China's Betta Pharmaceuticals and Miami-based Xcovery have been working together for nearly a decade on X-396, a next-generation ALK inhibitor in lung cancer.

NewsXcovery Holdings, Inc. partnered with Bettapharma on Jan 1st '26.Ensacove (ensartinib) is a next generation ALK inhibitor jointly developed by Xcovery and Betta Pharmaceuticals, Co. Ltd. (Betta).